ADAM17-induced shedding of glypican-1 as a mechanism of impaired endothelial shear stress mechanotransduction
American Journal of Physiology-Cell Physiology · 01.03.2026 · 330 (3) · C631-C642
DOI: 10.1152/ajpcell.00794.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.03.2026. Verfasst von Marc A Augenreich und 11 weiteren Autor:innen. Beteiligte Einrichtung: NextGen Precision Health, University of Missouri, Columbia, Missouri, United States. Hauptthemen laut MEDLINE: ADAM17 Protein, Mechanotransduction, Cellular, Glypicans, Endothelial Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, American Heart Association (AHA), HHS | National Institutes of Health (NIH).
Abstract (Originalsprache)
We provide evidence that neuraminidase, which is elevated in plasma from males and females with type 2 diabetes (T2D), is involved in the activation of endothelial ADAM17 and shedding of the mechanosensor glypican-1. We also provide evidence that neuraminidase-induced ADAM17 activation and consequent glypican-1 shedding are mediated by ANO6 scramblase externalization of phosphatidylserine. Together, this work suggests the neuraminidase-ANO6-ADAM17 axis may be a mechanism underlying impaired endothelial shear stress mechanotransduction in T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NextGen Precision Health, University of Missouri, Columbia, Missouri, United States.
- Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, Missouri, United States.
- Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
- Department of Surgery, University of Missouri, Columbia, Missouri, United States.
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Missouri, Columbia, Missouri, United States.
- Harry S. Truman Memorial Veterans' Hospital, Columbia, Missouri, United States.
ORCID-Profile: Marc A Augenreich, Larissa Ferreira-Santos, Gavin Power, Francisco I Ramirez-Perez, Juan D Gonzalez-Vallejo, Natnicha Imkaew, Min Jeong Cho, Andrew A Wheeler, Camila Manrique-Acevedo, Luis A Martinez-Lemus, Jaume Padilla
Förderung
- NHLBI NIH HHS
- American Heart Association (AHA)
- HHS | National Institutes of Health (NIH)
- NIGMS NIH HHS
- NIDDK NIH HHS
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Zitieren
APA
Augenreich, M. A., Ferreira-Santos, L., Power, G., Ramirez-Perez, F. I., Gonzalez-Vallejo, J. D., Williams, M. B., Imkaew, N., Cho, M. J., Wheeler, A. A., Manrique-Acevedo, C., Martinez-Lemus, L. A., & Padilla, J. (2026). ADAM17-induced shedding of glypican-1 as a mechanism of impaired endothelial shear stress mechanotransduction. American Journal of Physiology-Cell Physiology, 330(3), C631-C642. https://doi.org/10.1152/ajpcell.00794.2025
Vancouver
Augenreich MA, Ferreira-Santos L, Power G, Ramirez-Perez FI, Gonzalez-Vallejo JD, Williams MB, et al. ADAM17-induced shedding of glypican-1 as a mechanism of impaired endothelial shear stress mechanotransduction. American Journal of Physiology-Cell Physiology. 2026;330(3):C631-C642. doi:10.1152/ajpcell.00794.2025
BibTeX
@article{Augenreich2026,
author = {Augenreich, Marc A and Ferreira-Santos, Larissa and Power, Gavin and Ramirez-Perez, Francisco I and Gonzalez-Vallejo, Juan D and Williams, Morgan B and Imkaew, Natnicha and Cho, Min Jeong and Wheeler, Andrew A and Manrique-Acevedo, Camila and Martinez-Lemus, Luis A and Padilla, Jaume},
title = {ADAM17-induced shedding of glypican-1 as a mechanism of impaired endothelial shear stress mechanotransduction},
journal = {American Journal of Physiology-Cell Physiology},
year = {2026},
volume = {330},
number = {3},
pages = {C631--C642},
doi = {10.1152/ajpcell.00794.2025}
}
EUVIMED